Smiling Young Boy Visiting His Pediatrician

Moving Toward Early Diagnosis

Population-based screening for risk factors could help change the course of type 1 diabetes Researchers have known for some time that the risk of developing type 1 diabetes (T1D) can be detected by looking for the presence of specific autoantibodies. That knowledge has allowed JDRF to support TrialNet, a project that screens close relatives of people […]

Discovering the Best Size and Shape for Beta Cell Replacement

Discovering the Best Size and Shape for Beta Cell Replacement

Watch this: To learn more from MIT’s Dr. Anderson. Smaller Is Not Always Stealthier In a recent Nature Materials’ publication, Daniel Anderson, Ph.D., of the Massachusetts Institute of Technology (MIT) detailed how the immune system responds to implanted material depending on its size and shape. In this short video, you can learn about the future […]

White House Honors Tidepool for Its Development of T1D Data Technology

New apps help simplify T1D management Tidepool™—a JDRF-supported nonprofit committed to reducing the burden of type 1 diabetes (T1D)—has received a White House Champion of Change Precision Medicine Award for its work to develop innovative, open-source software and mobile phone apps that help people with T1D better manage the disease. The technologies will provide tools […]

One Drug’s To-Do List Could Grow

An osteoporosis medication could help restore insulin production in people with type 1 diabetes Type 1 diabetes (T1D) is caused by an autoimmune attack on insulin-producing beta cells, but studies have shown that many adults with long-term T1D are able to maintain some of their beta cells. One potential approach to curing the disease is […]

JDRF Response to CrossFit

At JDRF, we don’t believe diabetes is a laughing matter or something to be joked about. During the week of June 29, CrossFit posted insensitive images and misleading information regarding diabetes, both type 1 and type 2. JDRF chose to take a positive approach and educate the members of the CrossFit social media team on the differences […]

Well-Timed AP Technology Offers Peace of Mind in the UK

A JDRF-funded study at the University of Cambridge showed that an overnight treat-to-range device improved glucose control A recent JDRF-funded study at the University of Cambridge has found that unsupervised, at-home use of a treat-to-range artificial pancreas system can improve blood-glucose control throughout the night and into the next day. You can click on the […]

JDRF Draws a Winning Encapsulation Strategy

JDRF video demonstrates the differences between micro-encapsulation and macro-encapsulation A new video, “Sketching Encapsulation,” was created for JDRF’s FY2014 Annual Report. Albert J. Hwa, Ph.D., Director of Discovery Research at JDRF, explains encapsulation and outlines four encapsulation projects that are currently supported by JDRF. “Over the last seven years, JDRF has cultivated several encapsulation research […]

DexCom CGM System to Offer Real-Time Glucose Data Sharing

DexCom G4® Platinum Continuous Glucose Monitoring System with Share Allows Users to Wirelessly Transmit Blood-Glucose Data and Alerts to Up to Five “Followers” in Real-Time    Medical device manufacturer DexCom is rolling out the first FDA-approved continuous glucose monitoring (CGM) system that allows real-time sharing of blood-glucose data. The DexCom G4® Platinum Glucose Monitoring System with […]

Investigating the Role of Regulatory T Cells in T1D

A video explains a potential new immune therapy in the words of the T1D investigator and one of the clinical study participants JDRF Research in the Field spoke to the lead investigator, Dr. Stephen Gitelman at the University of California San Francisco’s Children’s Hospital, who enrolled 14 people recently diagnosed with Type 1 Diabetes (T1D) […]

Next-Generation Artificial Pancreas System Launches

Medtronic’s New MiniMed®640G Artificial Pancreas System Predicts and Helps Prevent Deadly Low Glucose Emergencies A four year-old Australian boy with type 1 diabetes (T1D) is the first person to use a groundbreaking commercial artificial pancreas system that can predict and automatically prevent low blood-glucose emergencies. Medtronic’s MiniMed® 640G is an insulin pump/continuous glucose monitor combination […]